Fund history

2018:
Fifth fund generation
SHS V (target volume: € 150 mn): Investments in fast-growing healthcare and medical technology companies with a focus on expansion financing, shareholder changes and succession situations.

A first subscription deadline of EUR 90 million took place in July 2018. Investors can still participate in the SHS V fund until the final closing or the maximum subscription amount is reached.
For more information please contact Hubertus Leonhardt.

SHS V Basisinformationsblatt Investor-Partner A
SHS V Basisinformationsblatt Investor-Partner B 

2013:
Fourth fund generation
SHS IV (€ 125 mn): Following the successful track record of SHS, SHS IV is going to invest in young innovative companies in the markets of medical technology and diagnostic in German speaking countries.

2008:
Third funds generation
SHS III (€ 50.5 mn): Investment in young technology companies in the life science and healthcare industry in German speaking countries.

2000:
Second funds generation
SHS IIa (€ 34.3 mn): Fully repaid
SHS IIb (€ 20 mn): Turn-around and growth.

1994:
First funds generation
SHS I (€ 16 mn): Fully repaid